By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
GMJ NewsGMJ NewsGMJ News
  • Latest News
    • GMJ Briefs
  • Podcast & Media
    • Podcast Episodes
    • GMJ Audio
    • GMJ Videos
  • Research Digest
    • New Studies
    • Georgian Research
    • Data & Numbers
  • Policy & Systems
    • Health Policy
    • Quality & Safety
    • Migration & Health
    • Global Health
  • Practice
    • Clinical Updates
    • Case Discussions
    • Pharmacy & Prescribing
    • Ingredients A-Z
  • Perspectives
    • Editorial
    • Explainers
    • Voices
    • Letters
  • GMJ Articles
    • Vol. 1 Issue 2 (2026)
    • Vol. 1 Issue 1 (2026)
    • Pre-Launch Articles (2025)
  • Read the Journal →
  • About GMJ News
Notification Show More
Font ResizerAa
GMJ NewsGMJ News
Font ResizerAa
  • Latest News
    • GMJ Briefs
  • Podcast & Media
    • Podcast Episodes
    • GMJ Audio
    • GMJ Videos
  • Research Digest
    • New Studies
    • Georgian Research
    • Data & Numbers
  • Policy & Systems
    • Health Policy
    • Quality & Safety
    • Migration & Health
    • Global Health
  • Practice
    • Clinical Updates
    • Case Discussions
    • Pharmacy & Prescribing
    • Ingredients A-Z
  • Perspectives
    • Editorial
    • Explainers
    • Voices
    • Letters
  • GMJ Articles
    • Vol. 1 Issue 2 (2026)
    • Vol. 1 Issue 1 (2026)
    • Pre-Launch Articles (2025)
  • Read the Journal →
  • About GMJ News
Follow US
GMJ News > GMJ Briefs > What Health Systems Must Know About Stigma and HIV Prevention Adherence

What Health Systems Must Know About Stigma and HIV Prevention Adherence

GMJ
Last updated: 01/07/2026 15:33
By
Prof. Giorgi Pkhakadze
Share
1 Min Read
Healthcare worker providing HIV prevention counseling to women in Zambian clinic setting
Research from Zambia shows women sex workers experiencing discrimination are 65% more likely to discontinue HIV prevention medication within three months. The study reveals how multiple forms of stigma create barriers to sustained PrEP use despite elevated HIV risks. — Photo: Nataliya Vaitkevich / Pexels
SHARE
1 min read|135 words

A groundbreaking study from Zambia offers critical lessons for health systems seeking to improve HIV prevention outcomes. Researchers identified three overlapping forms of stigma—chronic discrimination (28.2%), PrEP-specific stigma (22.5%), and HIV-related stigma (20.2%)—that collectively undermine medication adherence among sex workers. The key takeaway: addressing occupational stigma is essential to preventing early medication discontinuation. Women experiencing high chronic discrimination had a 65% increased risk of stopping PrEP within three months, despite facing 21-fold higher HIV acquisition risk than the general population. For health providers and policymakers, this means anti-stigma interventions are not optional add-ons but core components of HIV prevention programs. Creating safe, non-judgmental clinical environments and addressing societal discrimination against sex workers are prerequisites for effective biomedical prevention. The study demonstrates that without addressing structural barriers alongside medication provision, prevention tools cannot reach their full protective potential.

Was this article helpful?

GMJ Brief · Takeaway

📰 Read the full article: Discrimination linked to early HIV prevention dropout among sex workers in Zambia →

Related reference
  • Iron · Ingredient
Share This Article
Facebook LinkedIn Bluesky Copy Link Print
GMJ
ByProf. Giorgi Pkhakadze
Follow:
Prof. Giorgi Pkhakadze, MD, MPH, PhD, is Editor-in-Chief of the Georgian Medical Journal and Chair of the Public Health Institute of Georgia (PHIG). He is Professor and Head of the Department of Social and Behavioural Sciences at David Tvildiani Medical University, and Secretary/Treasurer of the UEMS Section of Public Health. ORCID: 0000-0001-7609-4515.

Submit Your Paper →

Georgia's peer-reviewed open-access medical journal. No APC until January 2027.
Submit Manuscript →
US Infant Mortality Reaches Historic Low, Yet Lags Peer Nations

The United States achieved an all-time low in infant mortality in 2025…

AI-Driven Depression Treatment Platform Neumora Halts Clinical Development

Neumora, an AI-focused depression treatment platform backed by venture capital firm ARCH,…

How one biotech startup transformed clinical trial failure into an AI-powered health technology breakthrough

A biotech startup has converted data from a failed clinical trial into…

Submit Your Paper to GMJ

No APC until January 2027.
Submit Manuscript →

You Might Also Like

American Diabetes Association conference presentation on MAHA health strategy

NIH Presents MAHA Initiative to Diabetes Research Community Amid Funding Concerns

By
Prof. Giorgi Pkhakadze
23/06/2026
Clinical UpdatesHealth PolicyPolicy & SystemsPractice

UK launches emergency meningitis B vaccine programme for students after deadly outbreak

By
Prof. Giorgi Pkhakadze
02/07/2026
Medical chart showing beta blocker outcomes data from international heart attack study

Four Decades of Cardiac Protocol Under Review: International Trial Questions Beta Blocker Use Post-Heart Attack

By
Prof. Giorgi Pkhakadze
26/06/2026
Infographic showing key risk factors for child wasting in Ghana including diarrheal episodes and maternal education

Advanced Machine Learning Identifies Child Wasting Risk Factors in Ghana

By
Prof. Giorgi Pkhakadze
07/06/2026
Facebook Twitter Youtube Instagram
Company
  • Privacy Policy
  • Contact US
  • GMJ Journal
  • Submit Manuscript
  • Editorial Team
  • Register at GMJ
  • Terms of Use

Subscribe to GMJ News — Click here

Join Community
© 2026 Georgian Medical Journal (GMJ). Published by the Public Health Institute of Georgia (PHIG). All rights reserved.
Welcome Back!

Sign in to your account

Username or Email Address
Password

Lost your password?

Not a member? Sign Up